The endogenous substance FGF21 has beneficial effects on blood lipids and glucose levels in rodents and monkeys, and is an interesting candidate for treatment of type 2 diabetes. Scientists at Karolinska Institutet have now examined if FGF21 has a similar function in humans. The results are presented in the journal Cell Metabolism.
Disorders of […]










